Forbes November 6, 2024
Donald Trump is now the second person in American history to win two non-consecutive Presidential terms, having presumptively secured victory in the race last night. Here’s a few initial thoughts about what that might mean for the healthcare industry.
More M&A Activity: Although Trump’s first term had more aggressive antitrust activity than a typical Republican administration, Wall Street widely expects a second Trump term to be more conducive to acquisitions. “This should lift whatever overhang exists from the current administration seeking to block some larger acquisitions by pharmaceutical firms, which should increase M&A activity,” Niels Peetz-Larsen, partner at HighVista Strategies, said in a note.
Possible Slowdown In Biotech Investment: Trump’s win led to a spike in bond yields and the...
Today's Sponsors
Today's Sponsor